Launch a Peptide Program in Days, Not Months

Launching a peptide program the traditional way is slow only because the regulated infrastructure gets rebuilt each time. When that infrastructure already exists and is shared across programs, adding peptide stops being a build and becomes a configuration. On Wizlo, a clinic already running one telehealth line can switch on peptide in days, inheriting the providers, protocols, pharmacy routing, and payments it already trusts.

The turnkey model works because the hard, regulated parts are common across programs. The same 50-state provider network, the same 40+ pharmacy routing waterfall, and the same Wizlo Pay processing that power your existing clinic extend to your peptide program without new vendors or new integrations. You inherit a proven operation instead of standing up a parallel one.

Speed here is revenue. Every month a peptide clinic spends building a peptide line the hard way is demand captured by someone else. A turnkey launch lets you meet that demand now, on the compliant, LegitScript-aligned foundation you already trust, and once peptide is live, it runs inside the same connected system as the rest of your patients.

Launching a peptide program is normally a months-long project because it means assembling providers, protocols, pharmacy fulfillment, and payments for a new line of care. On Wizlo, that infrastructure already exists and is shared across the platform, so adding peptide is a configuration you turn on rather than a build you start. Clinics that already run one telehealth line can go live with peptide in days.

The turnkey model works because the hard parts are common. Provider licensing, pharmacy failover, HIPAA architecture, and payment underwriting don't change from one program to the next, so once a peptide clinic has them for its first line, extending them to peptide costs almost nothing. That's why the marginal program is fast and cheap where the first one was slow and expensive.